Biel responds to FDA disapproval in today's news release. All positive moving forward. Stock sell off an over reaction which many will soon regret when 510k resubmitted and boat load of business ahead for company. I encourage reading letter response it will make you feel alot better about your investment.
(1)
(0)
BioElectronics Corporation (BIEL) Stock Research Links